ASSESSMENT OF COLLAGEN TYPE-II INDUCED ARTHRITIS IN MICE BY WHOLE-BLOOD CHEMILUMINESCENCE

被引：10

作者：

MIESEL, R ^{[1
]}

DIETRICH, A ^{[1
]}

ULBRICH, N ^{[1
]}

KROEGER, H ^{[1
]}

MITCHISON, NA ^{[1
]}

机构：

[1] DEUTSCH RHEUMA FORSCHUNGSZENTRUM,D-13353 BERLIN,GERMANY

来源：

AUTOIMMUNITY | 1994年 / 19卷 / 03期

关键词：

CHEMILUMINESCENCE; COLLAGEN; COLLAGEN-INDUCED ARTHRITIS;

D O I：

10.3109/08916939408995690

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Lucigenin-enhanced chemiluminescence can be measured in 100 mu l samples of whole, unseparated mouse blood. A procedure for doing so is here described in detail, using a standard clinical luminometer. The assay measures the TPA-induced oxidative burst from granulocytes and macrophages, which is believed to depend on the overall level of inflammation in the body. It is here applied to mice suffering from type II collagen-induced arthritis, and its relation to overt disease symptoms (the arthritis score) is characterised during the course of the disease. A correlation between the assay and the arthritis score is found al the height of the disease (r = 0.42, p = .039), but not at early or very late time points, although there is a strong hint that the results of an early assay may predict the subsequent disease course. The assay provides a rapid, convenient, quantitative and economical method of assessing disease activity, which can be carried out repeatedly on the same individual. It should be applicable in other mouse models of chronic inflammatory disease. It may find application for rapid screening of novel anti-rheumatic drugs and treatments.

引用

页码：153 / 159

页数：7

共 30 条

[1]

Lewis A.J., Carlson R.P., Chang J., Experimental models of inflammation, Handbook of inflammation 5: The pharmacology of inflammation, pp. 371-397, (1985)

[2]

Boissier M.C., Feng X.Z., Carlioz A., Roudier R., Fornier C., Experimental autoimmune arthritis in mice. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis, Ann. Rheum. Dis, 46, pp. 691-700, (1987)

[3]

Wooley P.H., Collagen-induced arthritis in the mouse, Meth. Enzymol, 162, pp. 361-373, (1988)

[4]

Holmdahl R., Andersson M., Goldschmidt T.J., Gustafsson K., Jansson L., Mo J.A., Type II collagen autoimmunity in animals and provocations leading to arthritis, Immunol. Rev, 118, pp. 193-232, (1990)

[5]

Wooley P.H., Luthra H.S., Stuart J.M., David C.S., Type II collagen-induced arthritis in mice. Major histocompatibility complex (I region) linkage and antibody response, J. Exp. Med, 154, pp. 688-700, (1981)

[6]

Suzuki K., Ota H., Sasagawa S., Sakatani T., Fujikura T., Assay method for myeloperoxidase in human polymorpho-nuclear leukocytes, Anal Biochem, 132, pp. 345-352, (1983)

[7]

Schorlemmer H.U., Davies P., Hylton W., Gugig M., Allison A.C., The release of lysosomal acidic hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation, Br. J. Exp. Pathol, 58, pp. 315-326, (1977)

[8]

Pepys M.B., Baltz M., Comer K., Davies A.J.S., Doenhoff M., Serum amyloid P-component is an acute phase reactant in the mouse, Nature, 278, pp. 259-261, (1979)

[9]

Bell R.B., Steinman L., Trimolecular interactions in experimental autoimmune demyelinating disease and prospects for immunotherapy, Semin. Immunol, 3, pp. 237-245, (1991)

[10]

Charriere C., Immune mechanisms in autoimmune thyroiditis, Advances in Immunol, 46, pp. 263-334, (1989)

← 1 2 3 →